ConductScience.org, home

Paper17697199

Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.

Shen J and 3 others. Aliment Pharmacol Ther, 2007. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis. Papers, record 17697199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17697199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
PubMed
Journal
Aliment Pharmacol Ther
PubMed
Year
2007
PubMed
Publication types
Journal Article, Meta-Analysis, Review
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
2.58
iCite
Revised in PubMed
2007-08-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shen JJ
2Ran ZHZ H
3Tong JLJ L
4Xiao SDS D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
Colitis, UlcerativeMajor topic
HeparinMajor topic
Analysis of Variance
Drug Therapy, Combination
Female
Humans
Male
Odds Ratio
Randomized Controlled Trials as Topic
Sensitivity and Specificity
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
40729235Cerebrovascular Thrombosis in Pediatric Ulcerative Colitis: A Case Report.Reports (MDPI)2025https://conductscience.org/library/papers/40729235PubMed
38407787Modern practical management of acute severe colitis.Indian J Gastroenterol2024https://conductscience.org/library/papers/38407787PubMed
38222957Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review.Euroasian J Hepatogastroenterol2023https://conductscience.org/library/papers/38222957PubMed
38202258Venous Thromboembolism in Patients with Inflammatory Bowel Disease.J Clin Med2023https://conductscience.org/library/papers/38202258PubMed
37063454Inflammatory Bowel Disease Therapy and Venous Thromboembolism.Curr Treat Options Gastroenterol2020https://conductscience.org/library/papers/37063454PubMed
36278572Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview.Diseases2022https://conductscience.org/library/papers/36278572PubMed
35608932Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel.J Crohns Colitis2022https://conductscience.org/library/papers/35608932PubMed
34970430How to manage: acute severe colitis.Frontline Gastroenterol2022https://conductscience.org/library/papers/34970430PubMed
34734325Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.AAPS PharmSciTech2021https://conductscience.org/library/papers/34734325PubMed
34599822The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry.J Crohns Colitis2022https://conductscience.org/library/papers/34599822PubMed
34453143International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/34453143PubMed
34377149Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.Ther Adv Gastroenterol2021https://conductscience.org/library/papers/34377149PubMed
32256013Venous thromboembolism in inflammatory bowel disease.World J Gastroenterol2020https://conductscience.org/library/papers/32256013PubMed
31689354Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.Inflamm Bowel Dis2020https://conductscience.org/library/papers/31689354PubMed
31562236British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.Gut2019https://conductscience.org/library/papers/31562236PubMed
25632199Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.World J Gastroenterol2015https://conductscience.org/library/papers/25632199PubMed
25320522Inflammatory bowel disease and thromboembolism.World J Gastroenterol2014https://conductscience.org/library/papers/25320522PubMed
24839622Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.Can J Gastroenterol Hepatol2014https://conductscience.org/library/papers/24839622PubMed
24744641Inflammatory bowel disease and thrombosis.Turk J Haematol2012https://conductscience.org/library/papers/24744641PubMed
24695669Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.World J Gastroenterol2014https://conductscience.org/library/papers/24695669PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17697199

GET https://conductscience.org/api/papers/v1/17697199/cited_by?page=2